Introduction:

Anorgasmia is the persistent, or recurrent, or absence of orgasm after a normal phase of sexual arousal, resulting in personal or interpersonal difficulties. Treatment is approached from different perspectives. Objective: To present the results of the effectiveness and safety of the use of the EROS-CTD in the management of female anorgasmia in a group of women from Quindío.

Materials and methods:

A descriptive, prospective observational study of case reports was carried out with women intervened by orgasm disorder in Armenia, Quindío, Colombia, from 2012 to 2017.

Results:

39 women were intervened whose average age was 35.1 (DS ± 3.7). Primary anorgasmia was 61.53% and the secondary was 38.36%. The average follow-up of the use of EROS-CTD was 23.7 (DS ± 4.5) months per patient. At the end of the study, overall satisfaction with the use of the device is 89.74%, none of the women presented complications related to the use of the appliance.

Conclusions:

The effectiveness of the treatment of female anorgasmia with EROS-CTD has benefited the women of the study.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )